You are here
Clinical Trials: Heart Attack
Each Clinical Trial will open in a new browser window or tab.
Condition: Coronary Artery Disease
Interventions: Combination Product: PCI with BioMatrix Alpha™ stent; Combination Product: PCI with Combo™ stent
Sponsors: Phillip Freeman; Aarhus University Hospital; Odense University Hospital; OrbusNeich; Biosensors International
Not yet recruiting
Interventions: Combination Product: PCI with BioMatrix Alpha™ stent; Combination Product: PCI with Combo™ stent
Sponsors: Phillip Freeman; Aarhus University Hospital; Odense University Hospital; OrbusNeich; Biosensors International
Not yet recruiting
Conditions: Left Ventricular Dysfunction; Acute Myocardial Infarction
Interventions: Biological: UC-MSC; Biological: Control Group
Sponsors: Shanghai Life Science & Technology; Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Not yet recruiting
Interventions: Biological: UC-MSC; Biological: Control Group
Sponsors: Shanghai Life Science & Technology; Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Not yet recruiting
Condition: Myocardial Infarction
Interventions: Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.; Procedure: Surgery by sternotomy
Sponsors: Fundació Institut Germans Trias i Pujol; Germans Trias i Pujol Hospital
Not yet recruiting
Interventions: Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.; Procedure: Surgery by sternotomy
Sponsors: Fundació Institut Germans Trias i Pujol; Germans Trias i Pujol Hospital
Not yet recruiting
Conditions: Diabetes Mellitus, Type 2; Coronary Artery Disease
Interventions: Dietary Supplement: Trans-resveratrol; Dietary Supplement: Placebo
Sponsors: Maine Medical Center; American Heart Association
Recruiting
Interventions: Dietary Supplement: Trans-resveratrol; Dietary Supplement: Placebo
Sponsors: Maine Medical Center; American Heart Association
Recruiting
Condition: HLHS
Intervention: Biological: Longeveron Mesenchymal Stem Cells
Sponsor: Longeveron LLC
Recruiting
Intervention: Biological: Longeveron Mesenchymal Stem Cells
Sponsor: Longeveron LLC
Recruiting
Condition: Myocardial Fibrosis
Interventions: Biological: iMP cells; Other: Control injection
Sponsors: Cell Therapy Ltd.; Royal Brompton & Harefield NHS Foundation Trust
Not yet recruiting
Interventions: Biological: iMP cells; Other: Control injection
Sponsors: Cell Therapy Ltd.; Royal Brompton & Harefield NHS Foundation Trust
Not yet recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting
Conditions: Refractory Angina; Chronic Myocardial Ischemia
Interventions: Device: CardiAMP Cell Therapy System; Other: Sham Treatment
Sponsor: BioCardia, Inc.
Not yet recruiting
Interventions: Device: CardiAMP Cell Therapy System; Other: Sham Treatment
Sponsor: BioCardia, Inc.
Not yet recruiting
Conditions: Hypoplastic Left Heart Syndrome; Heart Defects, Congenital; Pediatric Disorder
Intervention: Biological: Autologous Human Placental Cord Blood Mononuclear Cells
Sponsor: Murdoch Childrens Research Institute
Recruiting
Intervention: Biological: Autologous Human Placental Cord Blood Mononuclear Cells
Sponsor: Murdoch Childrens Research Institute
Recruiting
Condition: Heart Failure
Interventions: Drug: CardioCell; Drug: Placebos
Sponsors: John Paul II Hospital, Krakow; KCRI; National Center for Research and Development, Poland
Not yet recruiting
Interventions: Drug: CardioCell; Drug: Placebos
Sponsors: John Paul II Hospital, Krakow; KCRI; National Center for Research and Development, Poland
Not yet recruiting
